FDA Inspection
VitalantVitalant – FDA Inspection, Jan 9, 2018
Record Details
This FDA Inspection record concerns Vitalant, with an inspection on January 9, 2018, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · 5fb2f844-d192-4c57-902a-2a664dbf8035
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1037093
- FDA center
- Biologics
- Project area
- Blood and Blood Products
- Outcome
- Form 483 issued
FDA Citations
2- 21 CFR 630.10(g)(1)Proof Of Identity
- 21 CFR 606.40(a)(1)Provide space for examination
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Vitalant
6| Date | Classification | Office | Project area |
|---|---|---|---|
| May 18, 2026 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| September 8, 2021 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| December 10, 2015 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| June 19, 2014 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| March 28, 2012 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Vitalant
- FDA Inspection 1319318 - 2026-05-18
- FDA Inspection 1153285 - 2021-09-08
- FDA Inspection 951861 - 2015-12-10
- FDA Inspection 886438 - 2014-06-19
- FDA Inspection 774848 - 2012-03-28
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.